149 related articles for article (PubMed ID: 11170175)
1. Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells.
Guise S; Braguer D; Carles G; Delacourte A; Briand C
J Neurosci Res; 2001 Feb; 63(3):257-67. PubMed ID: 11170175
[TBL] [Abstract][Full Text] [Related]
2. Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells.
Kuhla B; Lüth HJ; Haferburg D; Weick M; Reichenbach A; Arendt T; Münch G
J Neurosci Res; 2006 Jun; 83(8):1591-600. PubMed ID: 16555297
[TBL] [Abstract][Full Text] [Related]
3. Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells.
Mookherjee P; Johnson GV
Brain Res; 2001 Dec; 921(1-2):31-43. PubMed ID: 11720709
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
5. Hyperosmotic stress-induced apoptosis and tau phosphorylation in human neuroblastoma cells.
Stoothoff WH; Johnson GV
J Neurosci Res; 2001 Sep; 65(6):573-82. PubMed ID: 11550225
[TBL] [Abstract][Full Text] [Related]
6. Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells.
Arnaud LT; Myeku N; Figueiredo-Pereira ME
J Neurochem; 2009 Jul; 110(1):328-42. PubMed ID: 19457109
[TBL] [Abstract][Full Text] [Related]
7. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition induces stress kinase dependent transport deficits--implications for Alzheimer's disease.
Agholme L; Nath S; Domert J; Marcusson J; Kågedal K; Hallbeck M
Mol Cell Neurosci; 2014 Jan; 58():29-39. PubMed ID: 24270002
[TBL] [Abstract][Full Text] [Related]
9. Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration.
Wang JZ; Wang ZH
Exp Gerontol; 2015 Aug; 68():82-6. PubMed ID: 25777063
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.
Nicolini G; Rigolio R; Miloso M; Bertelli AA; Tredici G
Neurosci Lett; 2001 Apr; 302(1):41-4. PubMed ID: 11278107
[TBL] [Abstract][Full Text] [Related]
11. Effects of cell cycle inhibitors on tau phosphorylation in N2aTau3R cells.
Conejero-Goldberg C; Townsend K; Davies P
J Mol Neurosci; 2008 Jun; 35(2):143-50. PubMed ID: 18278567
[TBL] [Abstract][Full Text] [Related]
12. Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells.
Shelton SB; Johnson GV
J Neurosci Res; 2001 Oct; 66(2):203-13. PubMed ID: 11592115
[TBL] [Abstract][Full Text] [Related]
13. Microtubule/MAP-affinity regulating kinase (MARK) is activated by phenylarsine oxide in situ and phosphorylates tau within its microtubule-binding domain.
Jenkins SM; Johnson GV
J Neurochem; 2000 Apr; 74(4):1463-8. PubMed ID: 10737602
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
16. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
17. Cis-4-methylsphingosine phosphate induces apoptosis in neuroblastoma cells by opposite effects on p38 and ERK mitogen-activated protein kinases.
Nätzker S; Heinemann T; Figueroa-Perez S; Schnieders B; Schmidt RR; Sandhoff K; van Echten-Deckert G
Biol Chem; 2002 Dec; 383(12):1885-94. PubMed ID: 12553725
[TBL] [Abstract][Full Text] [Related]
18. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors.
Wang HH; Li HL; Liu R; Zhang Y; Liao K; Wang Q; Wang JZ; Liu SJ
J Alzheimers Dis; 2010; 21(1):167-79. PubMed ID: 20413892
[TBL] [Abstract][Full Text] [Related]
19. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis.
Canu N; Dus L; Barbato C; Ciotti MT; Brancolini C; Rinaldi AM; Novak M; Cattaneo A; Bradbury A; Calissano P
J Neurosci; 1998 Sep; 18(18):7061-74. PubMed ID: 9736630
[TBL] [Abstract][Full Text] [Related]
20. Microtubule destruction induces tau liberation and its subsequent phosphorylation.
Miyasaka T; Sato S; Tatebayashi Y; Takashima A
FEBS Lett; 2010 Jul; 584(14):3227-32. PubMed ID: 20561519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
